Providing greater certainty in mole evaluation.
Orlucent® has developed the first handheld fluorescent molecular imaging system to non-invasively evaluate early tissue remodeling that signals a mole’s transition to atypia.
Higher fluorescence indicates probable tissue remodeling
Reveal suspicious tissue remodeling invisible to the naked eye
The Orlucent system evaluates biological activity originating from within the mole
Low biological activity
Significant biological activity with high probability of transition from benign to atypia
Low biological activity
Significant biological activity with high probability
of transition from benign to atypia
Current mole evaluation methods are visual and subjective - Tissue remodeling is indicative of a nevus transforming to atypia and atypical nevi have a potential to become melanoma.1 Unfortunately, current visual assessment methods are not always sufficient to distinguish between benign or suspicious atypical moles.2-4 For this reason, biopsy is often used to gain histopathological information. However, this takes time and biopsies have some risk of causing infection and scarring.
The Orlucent system is biologically based and objective - Addressing physician desire for improved mole evaluation tools5-7 the Orlucent system was developed with the aim of increasing efficiency and reducing subjectivity and invasiveness in the identification of moles with potential to develop into malignancy.
1 Friedman et al. The "dysplastic" nevus
5 March et al. Practical application of new technologies for melanoma diagnosis: Part I
6 Angelucci D. Diagnosis: Melanoma: What emerging tests and tech mean for dermatologists
©2023 Orlucent, Inc. Los Gatos, California, USA Contact: [email protected]
LBL0246 A
Currently in clinical trials. Research Use Only.